Please login to the form below

Not currently logged in
Email:
Password:

Boston Pharmaceuticals

This page shows the latest Boston Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

J&J adds Israel to list of bioincubators

J&J adds Israel to list of bioincubators

groups. Meanwhile, alongside its own offices J&J is also forging collaborations with established bioincubators in Montreal, Toronto, San Francisco and Boston. ... Boston has added programmes with Assembly Pharmaceuticals on viral infections and Nodality

Latest news

  • Scratching the surface

    Japan, Spain. Carbohydrate polymer . TAXUS Element (Angiotech Pharmaceuticals/Boston Scientific Corporation). Restinosis. ... Trials are ongoing for Celgene Corporation's apremilast, Biocon's T1h, and Taro Pharmaceuticals' desoximetasone topical spray.

  • A brighter future

    Epiduo (Galderma). Acne. UK. Rifaximin 550mg tablets. Xifaxan (Salix Pharmaceuticals). Overt hepatic encephalopathy (HE) recurrence. ... CAMBIA (Nautilus Neurosciences). Migraine. US. Paclitaxel-eluting coronary stent systems. TAXUS Element (Angiotech

  • News in brief, June 07, 2007

    FWP which is majority controlled by Frostrow Capital and is managed from Boston by US pharmaceuticals manager Sam Islay from Orbimed Advisers. ... In March 2007, Barr Pharmaceuticals made a Paragraph IV challenge against Otsuka regarding the aripiprazole

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Vertex poaches new finance chief from Ironwood Pharmaceuticals Vertex poaches new finance chief from Ironwood Pharmaceuticals

    Vertex poaches new finance chief from Ironwood Pharmaceuticals. Boston-based biotech company appoints Tom Graney. ... Vertex lured Tom Graney away from Ironwood Pharmaceuticals, appointing him as its new senior vice president and chief financial officer.

  • Juniper Pharmaceuticals adds to board of directors Juniper Pharmaceuticals adds to board of directors

    Juniper Pharmaceuticals adds to board of directors. Mary Ann Gray joins as audit committee chair. ... Boston-based Juniper Pharmaceuticals has elected Mary Ann Gray to its board of directors and appointed her as its audit committee chair.

  • Boston Pharma appoints ex-Pfizer and Sanofi executives Boston Pharma appoints ex-Pfizer and Sanofi executives

    Boston Pharmaceuticals has appointed Santiago Arroyo as chief medical officer and Constantine Chinoporos as chief business officer to further build and develop its portfolio. ... He said: “ Boston Pharmaceuticals is intensely focused on efficient

  • Dr Sunita Zalani joins Intarcia Therapeutics as regulatory head Dr Sunita Zalani joins Intarcia Therapeutics as regulatory head

    Dr Sunita Zalani joins Intarcia Therapeutics as regulatory head. Moves to the Boston company from Onyx Pharmaceuticals. ... She joins the company from Amgen's Onyx Pharmaceuticals subsiary, where she served as vice president of global regulatory affairs.

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics